Access your Pro+ Content below.
Stage 3 meaningful use on the horizon
This article is part of the Pulse issue of Volume 3, Number 2, March/April 2015
Stage 3 of the U.S. Department of Health and Human Services' (HHS) meaningful use program may still be on the distant horizon, but its shape is coming into focus as controversy around stage 2 starts to ease. With stage 3 not expected to launch until 2017, the most the health IT industry knows at this point is 12 pages of recommendations from the federal Health IT Policy Committee's meaningful use workgroup. Those nascent measures fixate on improving and gauging medical outcomes, as well as population health, decision support and patient engagement -- the longstanding goals of stage 3 meaningful use as set forth in the original program in 2009. But underlying the recommendations -- which will form the backbone of proposed stage 3 rules anticipated soon -- is the concept of value-based reimbursement that HHS Secretary Sylvia Burwell announced in January, said Paul Tang, M.D., vice chairman of the workgroup and vice president and chief innovation and technology officer at the Palo Alto Medical Foundation. Under the new federal ...
Access this PRO+ Content for Free!
Features in this issue
Paper-based medical record systems aren't gone yet, but they're waning as providers install EHR software and complete meaningful use attestation.
Although no curtain call is planned for meaningful use attestation, it sure looks like stage 3 reporting won't carry the oomph -- or rigidness -- of stage 2.
Most agree that meaningful use has driven the development of EHRs, but vendors complain that this focus has distracted them from improving ease of use.
A successful healthcare analytics strategy combines six important pieces that our expert explains. Also learn pointers on how to carry out this data analytics plan.
News in this issue
Providers won't have to attest to stage 3 meaningful use until 2017. The objectives will hew closely to HHS' new value-based reimbursement approach.
The effect of industry feedback on the Health IT Policy Committee's recommendations for meaningful use stage 3 will soon be evident.